26/03/2019 11:25:00

Detailed Research: Economic Perspectives on Biogen, Invesco, Bunge, Concho Resources, Maximus, and Meredith — What Drives Growth in Today's Competitive Landscape

NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Biogen Inc. (NASDAQ:BIIB), Invesco Ltd. (NYSE:IVZ), Bunge Limited (NYSE:BG), Concho Resources Inc. (NYSE:CXO), Maximus, Inc. (NYSE:MMS), and Meredith Corporation (NYSE:MDP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BIIB DOWNLOAD: https://MarketSourceResearch.com/register/?so=BIIB

IVZ DOWNLOAD: https://MarketSourceResearch.com/register/?so=IVZ

BG DOWNLOAD: https://MarketSourceResearch.com/register/?so=BG

CXO DOWNLOAD: https://MarketSourceResearch.com/register/?so=CXO

MMS DOWNLOAD: https://MarketSourceResearch.com/register/?so=MMS

MDP DOWNLOAD: https://MarketSourceResearch.com/register/?so=MDP

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Biogen Inc. (NASDAQ:BIIB), Invesco Ltd. (NYSE:IVZ), Bunge Limited (NYSE:BG), Concho Resources Inc. (NYSE:CXO), Maximus, Inc. (NYSE:MMS), and Meredith Corporation (NYSE:MDP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice:

the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 22nd, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

BIOGEN INC. (BIIB) REPORT OVERVIEW

Biogen's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Biogen reported revenue of $3,526.30MM vs $3,307.00MM (up 6.63%) and analysts estimated basic earnings per share $4.73 vs -$1.40. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Biogen reported revenue of $13,452.90MM vs $12,273.90MM (up 9.61%) and analysts estimated basic earnings per share $21.63 vs $11.94 (up 81.16%). Analysts expect earnings to be released on April 23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $6.05. The estimated EPS forecast for the next fiscal year is $29.20 and is expected to report on February 4th, 2020.

To read the full Biogen Inc. (BIIB) report, download it here: https://MarketSourceResearch.com/register/?so=BIIB

-----------------------------------------

INVESCO LTD. (IVZ) REPORT OVERVIEW

Invesco's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Invesco reported revenue of $1,255.90MM vs $1,375.60MM (down 8.70%) and analysts estimated basic earnings per share $0.28 vs $1.00 (down 72.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Invesco reported revenue of $5,314.10MM vs $5,160.30MM (up 2.98%) and analysts estimated basic earnings per share $2.14 vs $2.75 (down 22.18%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.67. The estimated EPS forecast for the next fiscal year is $2.60 and is expected to report on January 29th, 2020.

To read the full Invesco Ltd. (IVZ) report, download it here: https://MarketSourceResearch.com/register/?so=IVZ

-----------------------------------------

BUNGE LIMITED (BG) REPORT OVERVIEW

Bunge's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Bunge reported revenue of $11,543.00MM vs $11,605.00MM (down 0.53%) and analysts estimated basic earnings per share -$0.52 vs -$0.48. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Bunge reported revenue of $45,743.00MM vs $45,794.00MM (down 0.11%) and analysts estimated basic earnings per share $1.65 vs $0.90 (up 83.33%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $3.46 and is expected to report on February 20th, 2020.

To read the full Bunge Limited (BG) report, download it here: https://MarketSourceResearch.com/register/?so=BG

-----------------------------------------

CONCHO RESOURCES INC. (CXO) REPORT OVERVIEW

Concho Resources' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Concho Resources reported revenue of $1,067.00MM vs $780.00MM (up 36.79%) and basic earnings per share $7.81 vs $1.80 (up 333.89%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Concho Resources reported revenue of $4,151.00MM vs $2,586.00MM (up 60.52%) and analysts estimated basic earnings per share $13.28 vs $6.44 (up 106.21%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $1.00. The estimated EPS forecast for the next fiscal year is $6.98 and is expected to report on February 18th, 2020.

To read the full Concho Resources Inc. (CXO) report, download it here: https://MarketSourceResearch.com/register/?so=CXO

-----------------------------------------

MAXIMUS, INC. (MMS) REPORT OVERVIEW

Maximus' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Maximus reported revenue of $664.62MM vs $623.15MM (up 6.66%) and analysts estimated basic earnings per share $0.86 vs $0.90 (down 4.44%). For the twelve months ended September 30th, 2018 vs September 30th, 2017, Maximus reported revenue of $2,392.24MM vs $2,450.96MM (down 2.40%) and analysts estimated basic earnings per share $3.37 vs $3.19 (up 5.64%). Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.82. The estimated EPS forecast for the next fiscal year is $4.12 and is expected to report on November 19th, 2019.

To read the full Maximus, Inc. (MMS) report, download it here: https://MarketSourceResearch.com/register/?so=MMS

-----------------------------------------

MEREDITH CORPORATION (MDP) REPORT OVERVIEW

Meredith's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Meredith reported revenue of $853.50MM vs $417.70MM (up 104.33%) and analysts estimated basic earnings per share -$0.03 vs $3.55. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Meredith reported revenue of $2,247.40MM vs $1,713.30MM (up 31.17%) and analysts estimated basic earnings per share $1.48 vs $4.23 (down 65.01%). Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.74. The estimated EPS forecast for the next fiscal year is $8.38 and is expected to report on August 9th, 2019.

To read the full Meredith Corporation (MDP) report, download it here: https://MarketSourceResearch.com/register/?so=MDP

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Hugo Moreau, Media Department

Office: +1 (704) 343-6361

E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Related content
17 Sep - 
INVESTOR ACTION REMINDER: The Schall Law Firm Announces..
17 Sep - 
The Klein Law Firm Reminds Investors of Class Actions o..
17 Sep - 
Biogen Ranked #1 Biotechnology Company on Dow Jones Sus..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UPDATE - Yoko Ono and John Lennon Educational Tour Bus “Imagine A City With No Gun Violence!”
2
Translate Bio Announces Pricing of Public Offering of Common Stock
3
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pluralsight, Inc. - PS
4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SAExploration Holdings, Inc. - SAEX
5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

Related stock quotes

Biogen Inc 238.70 1.1% Stock price increasing
Concho Resources Inc 74.38 -2.3% Stock price decreasing
Meredith Corporation 36.18 -2.2% Stock price decreasing
Maximus Inc 80.42 1.2% Stock price increasing
Invesco Ltd 17.04 -1.1% Stock price decreasing
Bunge Limited 56.66 -2.0% Stock price decreasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 September 2019 11:21:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB6 - 2019-09-18 12:21:56 - 2019-09-18 11:21:56 - 1000 - Website: OKAY